Rationale for therapeutic silencing of alpha-synuclein in Parkinson's disease
about
Development of Nonviral Vectors Targeting the Brain as a Therapeutic Approach For Parkinson's Disease and Other Brain Disorders.Dysregulation of the causative genes for hereditary parkinsonism in the midbrain in Parkinson's disease.Immunotherapeutic Approaches Targeting Amyloid-β, α-Synuclein, and Tau for the Treatment of Neurodegenerative Disorders.
P2860
Rationale for therapeutic silencing of alpha-synuclein in Parkinson's disease
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Rationale for therapeutic silencing of alpha-synuclein in Parkinson's disease
@ast
Rationale for therapeutic silencing of alpha-synuclein in Parkinson's disease
@en
type
label
Rationale for therapeutic silencing of alpha-synuclein in Parkinson's disease
@ast
Rationale for therapeutic silencing of alpha-synuclein in Parkinson's disease
@en
prefLabel
Rationale for therapeutic silencing of alpha-synuclein in Parkinson's disease
@ast
Rationale for therapeutic silencing of alpha-synuclein in Parkinson's disease
@en
P2860
P356
P1433
P1476
Rationale for therapeutic silencing of alpha-synuclein in Parkinson's disease
@en
P2093
Demetrius M Maraganore
P2860
P356
10.14802/JMD.11001
P577
2011-04-30T00:00:00Z